Otros idiomas Geron Corporation

Acciones

GERN

US3741631036

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 27/06/2024			Varia. Cinco días.	Varia. 1 de enero.
4,44 ^USD	-0,22 %		-0,45 %	+110,43 %

12/06	Insider de Geron vendió acciones por valor de 1.334.129 dólares, según un reciente registro de la SEC	MT
10/06	GERON CORPORATION : Recibe una recomendación de compra del Barclays	ZM

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Inscripción 100% Gratuita

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	20/06
Geron Insider Sold Shares Worth $1,334,129, According to a Recent SEC Filing	12/06
Sector Update: Health Care Stocks Advance Friday Afternoon	07/06
Top Midday Gainers	07/06
Sector Update: Health Care Stocks Mixed Pre-Bell Friday	07/06
Jobs Growth Tops Forecasts as US Equity Futures Post Narrow Losses Pre-Bell	07/06
Sector Update: Health Care	07/06
Geron Announces FDA Approval of RYTELO, a First-in-Class Telomerase Inhibitor, for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia	07/06
Geron : RYTELO™ (imetelstat) FDA Approval Conference Call	07/06
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Friday Amid Focus on Upcoming Jobs Report	07/06
First-in-class telomerase inhibitor approved for blood cancer	07/06
Top Premarket Gainers	07/06
Geron Receives FDA Approval for Leukemia Treatment Rytelo; Shares Rise Pre-Bell	07/06
Geron Shares Rise Premarket on FDA Nod for Rytelo	07/06
Geron shares surge after U.S. FDA approves blood disorder drug	07/06
Geron Announces FDA Approval of RYTELO™ (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia	07/06
Geron Corporation Announces FDA Approval of RYTELO for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia	07/06
Certain Warrants of Geron Corporation are subject to a Lock-Up Agreement Ending on 3-JUN-2024.	03/06
Certain Stock options of Geron Corporation are subject to a Lock-Up Agreement Ending on 3-JUN-2024.	03/06
Certain Common Stock of Geron Corporation are subject to a Lock-Up Agreement Ending on 3-JUN-2024.	03/06

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Geron Corporation

Acciones

GERN

US3741631036

Otros idiomas

Filtros